Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akebia Therapeutics (AKBA) Non-Current Deferred Tax Liability (2018 - 2020)

Historic Non-Current Deferred Tax Liability for Akebia Therapeutics (AKBA) over the last 3 years, with Q1 2020 value amounting to $35.1 million.

  • Akebia Therapeutics' Non-Current Deferred Tax Liability rose 80604.03% to $35.1 million in Q1 2020 from the same period last year, while for Mar 2020 it was $35.1 million, marking a year-over-year increase of 80604.03%. This contributed to the annual value of $109.4 million for FY2019, which is 842.15% down from last year.
  • Akebia Therapeutics' Non-Current Deferred Tax Liability amounted to $35.1 million in Q1 2020, which was up 80604.03% from $109.4 million recorded in Q4 2019.
  • Akebia Therapeutics' Non-Current Deferred Tax Liability's 5-year high stood at $119.4 million during Q4 2018, with a 5-year trough of $1.8 million in Q3 2019.
  • Moreover, its 3-year median value for Non-Current Deferred Tax Liability was $19.5 million (2019), whereas its average is $45.4 million.
  • As far as peak fluctuations go, Akebia Therapeutics' Non-Current Deferred Tax Liability tumbled by 842.15% in 2019, and later soared by 80604.03% in 2020.
  • Over the past 3 years, Akebia Therapeutics' Non-Current Deferred Tax Liability (Quarter) stood at $119.4 million in 2018, then fell by 8.42% to $109.4 million in 2019, then plummeted by 67.9% to $35.1 million in 2020.
  • Its Non-Current Deferred Tax Liability stands at $35.1 million for Q1 2020, versus $109.4 million for Q4 2019 and $1.8 million for Q3 2019.